Title: Anticancer evaluation of Co(III) complex derived from 1-isonicotinoyl-4-(4-nitrophenyl)-3-thiosemicarbazide: Structural characterization, photophysical, and Hirshfeld studies
| dc.contributor.author | Ram Nayan Gautam | |
| dc.contributor.author | Alok Shukla | |
| dc.contributor.author | Suryansh Chandra | |
| dc.contributor.author | Sundeep Kumar | |
| dc.contributor.author | Arbind Acharya | |
| dc.contributor.author | Mamata K. Singh | |
| dc.contributor.author | Ray Jay Butcher | |
| dc.contributor.author | Manoj Kumar Bharty | |
| dc.date.accessioned | 2026-02-19T14:26:27Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | A new cationic complex, [Co((intph)(en)<inf>2</inf>]Cl, derived from the 1-isonicotinoyl-4-(4-nitrophenyl)-3-thiosemicarbazide (H<inf>2</inf>intph), is reported. The synthesized ligand and its corresponding Co(III) complex were successfully characterized by applying FT-IR and UV–visible spectroscopic techniques and single crystal ray diffraction data. Molecular geometries of the ligand and its Co(III) complex were accurately determined from their respective X-ray crystallographic analysis. The ligand and [Co((intph)(en)<inf>2</inf>]Cl crystallize in Triclinic and monoclinic systems with space groups P-1 and P 2<inf>1</inf>/n, respectively. The crystal structures of H<inf>2</inf>intph and [Co((intph)(en)<inf>2</inf>]Cl are stabilized by weak C-H⋯O, N-H⋯O, and C-H⋯Cl hydrogen bonding interactions. Hirshfeld surface analysis was accomplished to investigate intermolecular hydrogen bonding interactions found in ligand H<inf>2</inf>intph and [Co((intph)(en)<inf>2</inf>]Cl. The cytotoxicity of the ligand and the complex [Co((intph)(en)<inf>2</inf>]Cl was assessed for their anticancer potential against human glioblastoma (U87) and Dalton lymphoma (DL) cell lines. The complex exhibited IC<inf>50</inf> values of 100 μg/mL for U87 cells and 120 μg/mL for DL cells, indicating the concentration at which 50 % of cell viability was inhibited. In comparison, the ligand was less effective in the MTT assay against both U87 and DL cells. These results suggest that the complex [Co((intph)(en)<inf>2</inf>]Cl significantly reduces glioblastoma cell viability. Treatment with the complex induced cell death through both apoptotic and necrotic pathways, as evidenced by Hoechst/PI double staining. Additionally, there was an increase in intracellular reactive oxygen species (ROS), highlighting the role of oxidative stress in the anticancer activity of the [Co((intph)(en)<inf>2</inf>]Cl complex. Furthermore, fluorescence studies were carried out which revealed the order of fluorescence behaviors between the ligand and the Co(III) complex to be Co(III) complex > H<inf>2</inf>intph. © 2024 Elsevier B.V. | |
| dc.identifier.doi | 10.1016/j.inoche.2024.113521 | |
| dc.identifier.issn | 13877003 | |
| dc.identifier.uri | https://doi.org/10.1016/j.inoche.2024.113521 | |
| dc.identifier.uri | https://dl.bhu.ac.in/bhuir/handle/123456789/65038 | |
| dc.publisher | Elsevier B.V. | |
| dc.subject | Anticancer | |
| dc.subject | Co(III) complex | |
| dc.subject | Crystal structure | |
| dc.subject | Hirshfeld surface analysis | |
| dc.subject | Human glioblastoma | |
| dc.title | Anticancer evaluation of Co(III) complex derived from 1-isonicotinoyl-4-(4-nitrophenyl)-3-thiosemicarbazide: Structural characterization, photophysical, and Hirshfeld studies | |
| dc.type | Publication | |
| dspace.entity.type | Article |
